Technical420 Site Search

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) today announced it has appointed Dr. Jason Dyck as its new Chief Science Officer, and Chairman of its Scientific Advisory Board. (SAB). The appointment is in line with the Company's strategy to leverage the roots of its management team in medical cannabis, and…

With New York on the verge of legalizing recreational cannabis, we have seen an influx in questions concerning the US cannabis market. The US cannabis industry was the biggest winner of the 2020 general election and has been receiving much more mainstream media coverage since then. The combination of 8…

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) today announced that, further to the Company's press releases of January 5, 2021 , and March 12, 2021 , it has completed the first stage of the transaction to acquire Green Therapeutics LLC. The transaction is being completed in two parts, the first,…

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA" or the "Company") today announced that, further to the Company's press release of January 5, 2021 , AUSA has entered into a definitive agreement on March 11, 2021 with, among others, Green Therapeutics LLC ("GT") and the holders of the issued and…

Although we are still only in the first quarter of 2021, the number of reported acquisitions in the cannabis industry has already significantly surpassed the activity we saw in the first half of 2020. During the last month, we conducted significant due diligence on several leading cannabis companies that announced…

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA" or the "Company") today announced that, further to its press releases dated January 5, 2021 and February 24, 2021 , the Company has completed the acquisition of a 51% ownership interest in 2750176 Ontario Inc. ("ALPS") for initial consideration of $10,000,000 in shares…

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) today announced that the Company has entered into a binding terms sheet concerning a joint venture (JV) partnership with 3 Rivers Biotech Inc. ("3 Rivers"), a leading agricultural technology company specialised in commercial scale micropropagation, or plant tissue culture (PTC), for cannabis, hemp…

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF), today announced that the Company has filed its financials and management discussion and analysis for the third quarter of fiscal 2021, the period ending December 31, 2020. Condensed Interim Consolidated Statements of Financial Position (CNW Group/Australis Capital Inc.) Condensed Interim Consolidated Statements of…

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) announced today that, further to its press release dated January 5, 2021 , the Company has entered into a definitive agreement (the "Definitive Agreement") with the principals of ALPS for the acquisition of 51% of the issued and outstanding shares in ALPS (the…

The cannabis industry currently counts over 1,000 publicly listed companies. Consequently, it takes a lot to rise above the noise and stand out. Australis, in our opinion, is one of those companies that is uniquely differentiated, well led and poised to make an impact on the U.S. cannabis industry through…